Fernando C. Fervenza

Fernando C. Fervenza is a Professor of Medicine and Consultant in the Division of Nephrology & Hypertension at Mayo Clinic. He leads the Nephrology Collaborative Group, focusing on clinical research in parenchymal renal diseases, including glomerular diseases like membranous nephropathy and lupus nephritis. His work emphasizes translating bench research into bedside treatments, particularly targeting autoimmune mechanisms.

Education includes a PhD from the University of Oxford and MD from Pontificia Universidade Catolica do Rio Grande do Sul. He holds fellowships from the American Society of Nephrology and National Kidney Foundation, and serves as an Associate Editor for the Journal of the American Society of Nephrology.

Research interests span pathogenic antibodies, novel therapies for autoimmune kidney diseases, and clinical trials for conditions like ANCA-associated vasculitis. He leads major grants such as the Nephrotic Syndrome Rare Disease Clinical Research Network III and observational cohort studies in glomerular diseases.

Award-winning contributions include over 400 publications, with a focus on rituximab efficacy, clinical outcomes, and rare kidney disorders. His work bridges immunology, nephrology, and clinical practice to improve patient care.